跳至主要内容
临床试验/CTRI/2024/01/061097
CTRI/2024/01/061097尚未招募3 期

Efficacy and safety of carbetocin versus oxytocin in prevention of post partum hemorrhage in high risk women.An Open label randomised controlled trial - nil

DR SMRITI BAG0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Women of age between 18-35 years of Gestational age of 37-42 weeks
  • Patients who have given written informed consent Women at risk of PPH including
  • Factors resulting in overdistention of the uterus
  • Multiple gestation (eg, twins)
  • Fetal macrosomia
  • Polyhydramnios
  • Nature of labor and delivery
  • Induced labor
  • Precipitous labor (lasting less than 3 hours)
  • Prolonged labor
  • Forceps or vacuum-assisted delivery
  • Cesarean delivery
  • Factors relating to the placenta
  • Abruptio placentae
  • Placenta previa
  • Abnormal implantation
  • High multiparity
  • Preeclampsia
  • Chorioamnionitis
  • Amniotic fluid embolism
  • May precipitate disseminated intravascular coagulation, resulting in consumptive coagulopathy and uncontrolled blood loss
  • Under general Anesthesia
  • Medications
  • Prolonged oxytocin use
  • Magnesium sulfate
  • Anticoagulants

排除标准

  • Gestational age less than 37 or more than 42 weeks
  • History of thromboembolic disorders,
  • Cases suffering from chronic medical diseases (cardiac, hepatic, renal),
  • Not giving consent

研究者

发起方
DR SMRITI BAG

相似试验